Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Sanofi gets US FDA approval for new paediatric vaccine

      Sanofi gets US FDA approval for new paediatric vaccine

      Medical Dialogues Bureau27 Dec 2018 9:15 AM IST
      Sanofi developed the new paediatric vaccine, dubbed Vaxelis, in partnership with Merck.PARIS: The U.S. Food and Drug Administration approved Sanofi's...
      U.S. drug developer Capricor places Duchenne drug trial on hold

      U.S. drug developer Capricor places Duchenne drug trial on hold

      Medical Dialogues Bureau27 Dec 2018 9:00 AM IST
      The trial, named "HOPE-2", was testing the company's lead experimental drug CAP-1002, according to California-based Capricor's website.New Delhi:...
      Glenmark forays into branded dermatology segment in US

      Glenmark forays into branded dermatology segment in US

      Medical Dialogues Bureau26 Dec 2018 9:45 AM IST
      Glenmark is already present in generic dermatology market in the US.New Delhi: Glenmark Pharmaceuticals recently announced its foray into the branded...
      Strides gets USFDA nod to market laxative Polyethylene Glycol,Electrolytes in US

      Strides gets USFDA nod to market laxative Polyethylene Glycol,Electrolytes in US

      Medical Dialogues Bureau26 Dec 2018 9:30 AM IST
      Strides Pharma Global, Singapore, has received approval for laxative Polyethylene Glycol 3350 and Electrolytes for Oral Solution USP in the strengths...
      Big Pharma returning to U.S. price hikes in January after pause

      Big Pharma returning to U.S. price hikes in January after pause

      Medical Dialogues Bureau26 Dec 2018 9:05 AM IST
      The price hikes will pose a new challenge to President Donald Trump's pledge to lower the costs of prescription medications in the world's most...
      Thailands legislature legalizes medical use of marijuana

      Thailand's legislature legalizes medical use of marijuana

      Medical Dialogues Bureau26 Dec 2018 9:00 AM IST
      Recreational use of marijuana remains illegal and subject to prison terms and fines commensurate with the quantities involved.Bangkok: Thailand's...
      Johnson & Johnson talc issue: NGO writes to National Human Rights Commission

      Johnson & Johnson talc issue: NGO writes to National Human Rights Commission

      Medical Dialogues Bureau25 Dec 2018 9:35 AM IST
      The NGO has said that it has sought to draw the "urgent attention" of the rights panel, towards the relevance of the report on the baby talc powder...
      Aurobindo Pharma gets USFDA nod for Vecuronium Bromide Injection

      Aurobindo Pharma gets USFDA nod for Vecuronium Bromide Injection

      Medical Dialogues Bureau25 Dec 2018 9:30 AM IST
      Aurobindo Pharma said the product, used as part of general anaesthesia to provide skeletal muscle relaxation during surgery or mechanical ventilation,...
      Dr Reddys launches Aspirin and Dipyridamole capsules in US market

      Dr Reddy's launches Aspirin and Dipyridamole capsules in US market

      Medical Dialogues Bureau25 Dec 2018 9:15 AM IST
      Quoting IMS Health data, Dr Reddy's Laboratories said the Aggrenox brand and generic had US sales of approximately USD 182 million for the most recent...
      Shanghai Junshi Biosciences soars 21 percent on Hong Kong debut

      Shanghai Junshi Biosciences soars 21 percent on Hong Kong debut

      Medical Dialogues Bureau25 Dec 2018 9:00 AM IST
      Shanghai-based Junshi Biosciences has a pipeline of 13 biologic drug candidates, including immuno-oncology drugs and drugs targeting metabolic and...
      Lupin and AbbVie announces partnership to develop, commercialize Novel Oncology Drug

      Lupin and AbbVie announces partnership to develop, commercialize Novel Oncology Drug

      Medical Dialogues Bureau24 Dec 2018 9:30 AM IST
      Mumbai: Pharma major Lupin and global biopharmaceutical company AbbVie Inc., announced that AbbVie has licensed Lupin's MALT1 (Mucosa-Associated...
      Zydus Cadila gets USFDA nod for Doxycycline Hyclate delayed-release tablets,Febuxostat tablets

      Zydus Cadila gets USFDA nod for Doxycycline Hyclate delayed-release tablets,Febuxostat tablets

      Medical Dialogues Bureau24 Dec 2018 9:15 AM IST
      New Delhi: Zydus Cadila has received final approval from the US health regulator to market Doxycycline Hyclate delayed-release tablets, used to treat...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok